Singapore Health Sciences Authority - National regulatory authority for health products in Singapore
显示 2024 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| VELSIPITY FILM-COATED TABLET 2 MG | PFIZER PRIVATE LIMITED | VELSIPITY FILM-COATED TABLET 2 MG | May 30, 2024 | SIN17015P |
| TRICOR TABLET 160 MG | ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED | TRICOR TABLET 160 MG | May 29, 2024 | SIN17013P |
| Besremi Solution for Injection in Prefilled Syringe 500 micrograms/mL | PHARMAESSENTIA SINGAPORE PTE. LTD. | Besremi Solution for Injection in Prefilled Syringe 500 micrograms/mL | May 29, 2024 | SIN17014P |
| LENALIDOMIDE-TEVA CAPSULE 5mg | TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD. | LENALIDOMIDE-TEVA CAPSULE 5mg | May 17, 2024 | SIN17011P |
| LENALIDOMIDE-TEVA CAPSULE 15mg | TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD. | LENALIDOMIDE-TEVA CAPSULE 15mg | May 17, 2024 | SIN17009P |
| LENALIDOMIDE-TEVA CAPSULE 10mg | TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD. | LENALIDOMIDE-TEVA CAPSULE 10mg | May 17, 2024 | SIN17010P |
| PARECOXIB-AFT POWDER FOR SOLUTION FOR INJECTION 40MG | APEX PHARMA MARKETING PTE. LTD. | PARECOXIB-AFT POWDER FOR SOLUTION FOR INJECTION 40MG | May 17, 2024 | SIN17012P |
| AREXVY Powder and Suspension for Suspension for Injection 120mcg/0.5mL | GLAXOSMITHKLINE PTE LTD | AREXVY Powder and Suspension for Suspension for Injection 120mcg/0.5mL | May 10, 2024 | SIN17008P |
| PALBOCICLIB SANDOZ CAPSULE 125MG | NOVARTIS (SINGAPORE) PTE LTD | PALBOCICLIB SANDOZ CAPSULE 125MG | May 9, 2024 | SIN17007P |
| PALBOCICLIB SANDOZ CAPSULE 100MG | NOVARTIS (SINGAPORE) PTE LTD | PALBOCICLIB SANDOZ CAPSULE 100MG | May 9, 2024 | SIN17006P |
| PALBOCICLIB SANDOZ CAPSULE 75MG | NOVARTIS (SINGAPORE) PTE LTD | PALBOCICLIB SANDOZ CAPSULE 75MG | May 9, 2024 | SIN17005P |
| LUNSUMIO CONCENTRATE FOR SOLUTION FOR INFUSION 30MG/30ML | ROCHE SINGAPORE PTE. LTD. | LUNSUMIO CONCENTRATE FOR SOLUTION FOR INFUSION 30MG/30ML | May 8, 2024 | SIN17002P |
| PAZOPANIB-TEVA FC TABLETS 200 MG | TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD. | PAZOPANIB-TEVA FC TABLETS 200 MG | May 8, 2024 | SIN17000P |
| LUNSUMIO CONCENTRATE FOR SOLUTION FOR INFUSION 1MG/ML | ROCHE SINGAPORE PTE. LTD. | LUNSUMIO CONCENTRATE FOR SOLUTION FOR INFUSION 1MG/ML | May 8, 2024 | SIN17001P |
| ESCOPRO POWDER FOR SOLUTION FOR INJECTION/INFUSION 40MG/VIAL | APEX PHARMA MARKETING PTE. LTD. | ESCOPRO POWDER FOR SOLUTION FOR INJECTION/INFUSION 40MG/VIAL | May 8, 2024 | SIN17003P |
| YSP ALLOPURINOL TABLET 300MG | YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD | YSP ALLOPURINOL TABLET 300MG | May 8, 2024 | SIN17004P |
| INHIXA Solution for Injection 6000 Anti-Xa IU (60MG)/0.6ML | PHARMAZEN MEDICALS PTE LTD | INHIXA Solution for Injection 6000 Anti-Xa IU (60MG)/0.6ML | May 7, 2024 | SIN16997P |
| INHIXA Solution for Injection 2000 Anti-Xa IU (20MG)/0.2ML | PHARMAZEN MEDICALS PTE LTD | INHIXA Solution for Injection 2000 Anti-Xa IU (20MG)/0.2ML | May 7, 2024 | SIN16999P |
| INHIXA Solution for Injection 4000 Anti-Xa IU (40MG)/0.4ML | PHARMAZEN MEDICALS PTE LTD | INHIXA Solution for Injection 4000 Anti-Xa IU (40MG)/0.4ML | May 7, 2024 | SIN16998P |
| APRITANT IV powder for solution for injection 150mg/vial | GOLDPLUS UNIVERSAL PTE LTD | APRITANT IV powder for solution for injection 150mg/vial | May 6, 2024 | SIN16996P |
